S-Space

Browse

Author

Showing results 1 to 3 of 3

Issue Date	Title / Author(s) / Citation	File
2020-06	Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): A randomised, open-label, phase 2 trial Tolaney, Sara M.; Wardley, Andrew M.; Zambelli, Stefania; Hilton, John F.; Troso-Sandoval, Tiffany A.; Ricci, Francesco; Im, Seock-Ah; Kim, Sung-Bae; Johnston, Stephen R. D.; Chan, Arlene; Goel, Shom; Catron, Kristen; Chapman, Sonya C.; Price, Gregory L.; Yang, Zhengyu; Gainford, M. Corona; Andre, Fabrice The Lancet Oncology, Vol.21 No.6, pp.763-775	DOI
2023-08	AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer Tolaney, Sara M.; Chan, Arlene; Petrakova, Katarina; Delaloge, Suzette; Campone, Mario; Iwata, Hiroji; Peddi, Parvin F.; Kaufman, Peter A.; De Kermadec, Elisabeth; Liu, Qianying; Cohen, Patrick; Paux, Gautier; Wang, Lei; Ternès, Nils; Boitier, Eric; Im, Seock-Ah Journal of Clinical Oncology, Vol.41 No.24, pp.4014-4024	DOI
2024	Reply to Y. Yoshitomi et al Tolaney, Sara M.; De Kermadec, Elisabeth; Cohen, Patrick; Paux, Gautier; Wang, Lei; Im, Seock-Ah Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol.42 No.2, pp.241-242	DOI